Filana Therapeutics, Inc. (FLNA)
NASDAQ · Healthcare
Filana Therapeutics, Inc. Income Statement 2009–2013
| Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 41.1M | 10.9M | 11.5M | 16.8M | 20.6M |
| Gross Profit | — | — | — | — | — |
| Profitability | |||||
| Operating Income | 31.4M | -3.9M | -3.5M | -13.7M | -6.8M |
| EBITDA | — | -3.8M | -3.4M | -13.5M | -6.5M |
| Net Income | 31.5M | -3.4M | -2.6M | -12.0M | -3.5M |
| Per Share Data | |||||
| EPS (diluted) | $0.70 | $-0.08 | $-0.06 | — | — |
| Shares Outstanding (dil.) | 45M | 45M | 44M | 43M | — |
Filana Therapeutics, Inc. Income Statement — FAQ
Filana Therapeutics, Inc. (FLNA) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FLNA's income statement history?
The chart and table above show Filana Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.